Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Risperdal

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    45 result(s) found for: Risperdal. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2005-002304-41 Sponsor Protocol Number: RIS-SCH-4045 Start Date*: 2005-09-23
    Sponsor Name:Janssen-Cilag EMEA Medical Affairs
    Full Title: Early versus late initiation of treatment with Risperdal Consta in subjects with schizophrenia or schizoaffective disorder after an acute episode
    Medical condition: Schizophrenia or schizoaffective disorder.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed) DK (Completed) FI (Completed) GB (Completed) SI (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-004482-15 Sponsor Protocol Number: NRA 1280013 Start Date*: Information not available in EudraCT
    Sponsor Name:Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie
    Full Title: Hirnaktivierung während Gedächtnisaufgaben bei Patienten mit Schizophrenie unter Behandlung von Ziprasidon oder Risperidon. Eine FMRT-Untersuchung.
    Medical condition: Patienten mit DSM-IVTR diagnostizierter Schizophrenie
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-003781-14 Sponsor Protocol Number: RISBIM3003 Start Date*: 2004-12-02
    Sponsor Name:Johnson & Johnson Pharmaceutical Research and Development
    Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder,...
    Medical condition: BIPOLAR MANIA
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed) SK (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-000870-29 Sponsor Protocol Number: RISSCH3001 Start Date*: 2004-11-04
    Sponsor Name:Janssen-Cilag Medical Affairs EMEA
    Full Title: CONSTATRE Risperdal Consta Trial of Relapse Prevention and Effectiveness
    Medical condition: SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed) ES (Completed) AT (Completed) SE (Completed) CZ (Completed) LV (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-002694-22 Sponsor Protocol Number: R092670PSY3002 Start Date*: 2005-02-07
    Sponsor Name:Janssen-Cilag International N.V
    Full Title: A Randomized, Double-Blind, Parallel Group Non-inferiority Study of Flexibly Dosed Paliperidone Palmitate(25, 50, 75, 100 mg eq) Administered Every 4 weeks and Flexibly Dosed Risperdal Consta (25, ...
    Medical condition: schizophrenia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) AT (Completed) SE (Completed) CZ (Completed) DK (Completed) EE (Completed) ES (Completed) LT (Completed)
    Trial results: View results
    EudraCT Number: 2007-004857-27 Sponsor Protocol Number: F20REWARDLU Start Date*: 2008-01-02
    Sponsor Name:Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich
    Full Title: Ventral striatal function in patients with schizophrenia before and under medication with atypical antipsychotics: a comparison of sertindole and risperidone
    Medical condition: schizophrenic patients (F20.0, F20.1, F20.2, F20.3, F20.5, F20.6, F20.8, F20.9) and healthy controls
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004383-23 Sponsor Protocol Number: RISSCH4055 Start Date*: 2005-11-24
    Sponsor Name:Janssen Cilag Ltd
    Full Title: Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid...
    Medical condition: Schizophrenia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed) IE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004621-25 Sponsor Protocol Number: RIS-SCH-4043 Start Date*: 2006-01-30
    Sponsor Name:Janssen-Cilag Medical Affairs EMEA
    Full Title: Is premorbid functioning a predictor of outcome in patients with early onset psychosis treated with Risperdal Consta?
    Medical condition: Schizophrenia, schizoaffective disorder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039613 Schizo-affective type schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: LT (Completed) NL (Completed) BE (Completed) IT (Completed) PT (Completed) GR (Completed) IE (Completed)
    Trial results: View results
    EudraCT Number: 2006-001490-15 Sponsor Protocol Number: RIS-BMN-3001 Start Date*: 2007-04-23
    Sponsor Name:Janssen-Cilag International N.V
    Full Title: A randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the...
    Medical condition: Subjects with a diagnosos of bipolar I disorder who are currently experiencing a manic or mixed episode (YMRS>20 and CGI-S>/= 4 [moderate]) or who are between mood episodes (non-acute; YMRS<12 and ...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10004939 Bipolar I disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2009-012003-26 Sponsor Protocol Number: RIS-NAP-4022 Start Date*: 2010-04-13
    Sponsor Name:Janssen-Cilag International, NV
    Full Title: Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
    Medical condition: Long-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10039626 Schizophrenia LLT
    12.1 10026753 Manic and bipolar mood disorders and disturbances HLGT
    12.1 10003805 Autism LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Prematurely Ended) BE (Prematurely Ended) GR (Completed)
    Trial results: View results
    EudraCT Number: 2006-004891-10 Sponsor Protocol Number: Vocational Rehabilitation Start Date*: 2007-04-17
    Sponsor Name:Charité - Universitätsmedizin Berlin
    Full Title: Future strategies for vocational rehabilitation schizophrenia
    Medical condition: The social implications and long-term consequences of mental disorders regarding sick days at work, unemployment rates and early retirement are considerable. This trial is being conducted to unders...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039626 Schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-004034-32 Sponsor Protocol Number: 17-216 Start Date*: 2006-09-20
    Sponsor Name:Medizinische Universität Graz
    Full Title: Zur Frage des neuroleptikainduzierten metabolischen Syndroms. Studie 1: Fettverteilung und spezifische hormonelle Parameter. Eine prospektive Vergleichsstudie zwischen 5 atypischen Neuroleptika
    Medical condition: Einschlusskriterien: - Schizophrenie, schizoaffektive Störung oder akut polymorph psychotische Störung - Alter: zwischen 18 und 70 Jahren - Vorliegen einer schriftlichen Einverständniserklärung zu...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2007-004740-79 Sponsor Protocol Number: D1443L00039 Start Date*: 2008-06-10
    Sponsor Name:AstraZeneca GmbH
    Full Title: A One-Year Randomized, Prospective, Parallel, Open Comparison of Subjective Well-being in Schizophrenic Out-patients Treated with Quetiapine XR (SEROQUEL Prolong®) or Oral Risperidone at Flexible D...
    Medical condition: Schizophrenia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) FI (Completed) BE (Completed) PT (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-003340-11 Sponsor Protocol Number: R076477SCH4026 Start Date*: 2008-11-03
    Sponsor Name:JANSSEN-CILAG GmbH
    Full Title: The “therapeutic window” of the "atypical” antipsychotic paliperidone ER - A Positron Emission Tomography study with [18F]fallypride as the radiotracer
    Medical condition: subchronic schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039626 Schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-005010-22 Sponsor Protocol Number: LY03004/CT-EUR-101 Start Date*: 2019-04-26
    Sponsor Name:Nanjing Luye Pharmaceutical Co., Ltd.
    Full Title: A Randomized, Open-Label, Cross-over Study to Assess the Relative Bioavailability of LY03004 and EU Risperdal® Consta® at 50 mg Following Multiple Intramuscular Injections in Stable Patients with S...
    Medical condition: schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    20.0 10037175 - Psychiatric disorders 10039626 Schizophrenia PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: HR (Completed)
    Trial results: View results
    EudraCT Number: 2007-004246-32 Sponsor Protocol Number: D1443L00031 Start Date*: 2007-12-05
    Sponsor Name:ASTRAZENECA
    Full Title: Comparison of Quetiapine Extended-Release (Seroquel XR™ ) and Risperidone in the treatment of depressive symptoms, in schizophrenic or schizoaffective patients: A randomized, open label, flexible-d...
    Medical condition: Patient with schizophrenia or schizoaffective disorder with depressive symptoms
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039620 Schizoaffective and schizophreniform disorders HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-005772-13 Sponsor Protocol Number: AMISU_L_01008 Start Date*: 2008-01-28
    Sponsor Name:sanofi-aventis Zrt.
    Full Title: Comparative efficacy of amisulpride vs. risperidone on cognitive functions in patients with chronic schizophrenia.
    Medical condition: measure of overall cognitive functioning in chronic schizophrenia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2005-002979-33 Sponsor Protocol Number: RIS-USA-234 Start Date*: 2006-01-19
    Sponsor Name:Janssen-Cilag International N.V.
    Full Title: Estudio de la eficacia y seguridad de risperidona en el tratamiento de adolescentes con esquizofrenia: Estudio abierto de seis meses.
    Medical condition: SCHIZOPHRENIA/ Adolescents
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-011594-33 Sponsor Protocol Number: SMRI-07TGF-1152 Start Date*: 2009-11-02
    Sponsor Name:LWL University Hospital Bochum, Ruhr-University Bochum
    Full Title: A randomized, double-blind, placebo-controlled study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia
    Medical condition: Schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039626 Schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005485-36 Sponsor Protocol Number: RGH-188-005 Start Date*: 2013-04-17
    Sponsor Name:Gedeon Richter Plc
    Full Title: A kariprazin hatásosságának, biztonságosságának és tolerálhatóságának randomizált, kettős vak, párhuzamos csoportos vizsgálata túlnyomórészt negatív tünetes skizofrén betegeknél
    Medical condition: Patients with Predominant Negative Symptoms of Schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    16.1 10037175 - Psychiatric disorders 10039626 Schizophrenia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed) ES (Completed) PL (Completed) BG (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 18 07:55:54 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA